Complement factor H gene (CFH) polymorphisms C-257T, G257A and haplotypes are associated with protection against severe dengue phenotype, possible related with high CFH expression

Human Immunology

Volumn 74, Issue 9, 2013, Pages 1225-1230

  Pastor, André F ^a,c   Rodrigues Moura, Laís ^a   Neto, José W D ^a   Nascimento, Eduardo J M ^d   Calzavara Silva, Carlos E ^a   Gomes, Ana Lisa V ^a   Silva, Ana Maria da ^a   Cordeiro, Marli T ^a   Braga Neto, Ulisses ^b   Crovella, Sergio ^c   Gil, Laura H V G ^a   Marques, Ernesto T A ^a,d   Acioli Santos, Bartolomeu ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Department of Electrical and Computer Engineering   (United States)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHILD; DENGUE; FEMALE; GENE EXPRESSION; GENETIC CODE; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NEWBORN; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

CFH; COMPLEMENT FACTOR H; DENGUE FEVER; DENGUE VIRUS; DENV; DF; ODDS RATIO; OR; SD; SEVERE DENGUE;

ADOLESCENT; ADULT; AGED; BRAZIL; CHILD; CHILD, PRESCHOOL; COMPLEMENT FACTOR H; DENGUE; DENGUE VIRUS; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NF-KAPPA B; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 84880933334     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.05.005     Document Type: Article

References (43)

1. Gubler DKG. Dengue and dengue hemorrhagic fever. London; 1997.
2. Paradoa Perez M.L., Trujillo Y., Basanta P. Association of dengue hemorrhagic fever with the HLA system. Haematologia Budap 1987, 20:83-87.
3. Soundravally R., Hoti S.L. Immunopathogenesis of dengue hemorrhagic fever and shock syndrome: role of TAP and HPA gene polymorphism. Hum Immunol 2007, 68:973-979.
4. Sakuntabhai A., Turbpaiboon C., Casademont I., Chuansumrit A., Lowhnoo T., Kajaste-Rudnitski A., et al. A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 2005, 37:507-513.
5. Wang W.K., Chao D.Y., Kao C.L., Wu H.C., Liu Y.C., Li C.M., et al. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology 2003, 305:330-338.
6. Libraty D.H., Endy T.P., Houng H.S., Green S., Kalayanarooj S., Suntayakorn S., et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 2002, 185:1213-1221.
7. Bokisch V.A., Muller-Eberhard H.J., Dixon F.J. The role of complement in hemorrhagic shock syndrome (dengue). Trans Assoc Am Physicians 1973, 86:102-110.
8. Avirutnan P., Malasit P., Seliger B., Bhakdi S., Husmann M. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 1998, 161:6338-6346.
9. Avirutnan P., Punyadee N., Noisakran S., Komoltri C., Thiemmeca S., Auethavornanan K., et al. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis 2006, 193:1078-1088.
10. Acioli-Santos B., Segat L., Dhalia R., Brito C.A., Braga-Neto U.M., Marques E.T., et al. MBL2 Gene polymorphisms protect against development of thrombocytopenia associated with severe dengue phenotype. Hum Immunol 2008, 69:122-128.
11. Nascimento E.J., Silva A.M., Cordeiro M.T., Brito C.A.A., Gil L.H.V.G., Braga-Neto U., et al. Alternative complement pathway deregulation is correlated with dengue severity. PLoS ONE 2009, 4(8):e6782.
12. Sierra B de la C, Kouri G., Guzman M.G. Race: a risk factor for dengue hemorrhagic fever. Arch Virol 2007, 152:533-542.
13. Loke H., Bethell D.B., Phuong C.X., Dung M., Schneider J., White N.J., et al. Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?. J Infect Dis 2001, 184:1369-1373.
14. Burke D.S., Nisalak A., Johnson D.E. Scott RM A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 1988, 38:172-180.
15. Stephens H.A., Klaythong R., Sirikong M., Vaughn D.W., Green S., Kalayanarooj S., et al. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 2002, 60:309-318.
16. Chiewsilp P., Scott R.M., Bhamarapravati N. Histocompatibility antigens and dengue hemorrhagic fever. Am J Trop Med Hyg 1981, 30:1100-1105.
17. Fernandez-Mestre M.T., Gendzekhadze K., Rivas-Vetencourt P., Layrisse Z. TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue Antigens 2004, 64:469-472.
18. Loke H., Bethell D., Phuong C.X., Day N., White N., Farrar J., et al. Susceptibility to dengue hemorrhagic fever in vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes. Am J Trop Med Hyg 2002, 67:102-106.
19. Fang X., Hu Z., Shang W., Zhu J., Xu C., Rao X. Genetic polymorphisms of molecules involved in host immune response to dengue virus infection. FEMS Immunol Med Microbiol 2012, 1-13.
20. Tan G.K., Alonso S. Pathogenesis and prevention of dengue virus infection: state-of-the-art. Curr Opin Infect Dis 2009, 22:302-308.
21. Nishioka K. Serum complement level in dengue hemorrhagic fever. Allerg Immunol (Leipz) 1974, 20-21:385-392.
22. Wang W.K., Chen H.L., Yang C.F., Hsieh S.C., Juan C.C., Chang S.M., et al. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis 2006, 43:1023-1030.
23. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat immunol 2010, 11(9):785-797. New York.
24. Chung K.M., Liszewski M.K., Nybakken G., Davis A.E., Townsend R.R., Fremont D.H., et al. West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc Natl Acad Sci USA 2006, 103:19111-19116.
25. de Cordoba S.R., de Jorge E.G. Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clin Exp Immunol 2008, 151:1-13.
26. Williams S.A., Vik D.P. Characterization of the 5' flanking region of the human complement factor H gene. Scand J Immunol 1997, 45:7-15.
27. Cordeiro M.T., Schatzmayr H.G., Nogueira R.M., Oliveira V.F., Melo W.T., Carvalho E.F. Dengue and dengue hemorrhagic fever in the State of Pernambuco, 1995-2006. Rev Soc Bras Med Trop 2007, 40:605-611.
28. Cordeiro M.T., Silva A.M., Brito C.A., Nascimento E.J., Magalhaes M.C., Guimarães G.F., et al. Characterization of a dengue patient cohort in Recife. Brazil Am J Trop Med Hyg 2007, 77:1128-1134.
29. Warwicker P., Goodship T.H., Goodship J.A. Three new polymorphisms in the human complement factor H gene and promoter region. Immunogenetics 1997, 46:437-438.
30. Lanciotti R.S., Calisher C.H., Gubler D.J., Chang G.J., Vorndam A.V. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992, 30:545-551.
31. Gubler D.J., Kuno G., Sather G.E., Velez M., Oliver A. Use of mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue virus. Am J Trop Med Hyg 1984, 33:158-165.
32. Marques E.T., Maciel Filho R., August P.N. Overcoming health inequity: potential benefits of a patient-centered open-source public health infostructure. Cad Saude Publica 2008, 24:547-557.
33. Organization W.H. Dengue: guidelines for diagnosis treatment, prevention, and control 2004, The World Health Report. New ed.
34. Alencar LXE, Braga-Neto UL, Nascimento EJM, Cordeiro MT, Silva AM et al. HLA-B/44 is Associated with Dengue Severity Caused by DENV-3 in a Brazilian Population. Journal of Tropical Medicine 2013;2013:11. Article ID 648475. http://dx.doi.org/10.1155/2013/648475.
35. Caprioli J., Castelletti F., Bucchioni S., Bettinaglio P., Bresin E., Pianetti G., et al. Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum Mol Genet 2003, 12:3385-3395.
36. Shresta S. Role of Complement in Dengue Virus Infection: Protection or Pathogenesis?. mBio 2012, 3(1):e00003-e00012.
37. Avirutnan P., Zhang L., Punyadee N., Manuyakorn A., Puttikhunt C., Kasinrerk W., et al. Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog 2007, 3:e183.
38. Friese M.A., Hellwage J., Jokiranta T.S., Meri S., Peter H.H., Eibel H., et al. FHL-1/reconectin and factor H: two human complement regulators which are encoded by the same gene are differently expressed and regulated. Mol Immunol 1999, 36:809-818.
39. Timar K.K., Pasch M.C., van den Bosch N.H., Jarva H., Junnikkala S., Meri S., et al. Human keratinocytes produce the complement inhibitor factor H: synthesis is regulated by interferon-gamma. Mol Immunol 2006, 43:317-325.
40. Luo W., Vik D.P. Regulation of complement factor H in a human liver cell line by interferon-gamma. Scand J Immunol 1999, 49:487-494.
41. Halme J., Sachse M., Vogel H., Giese T., Klar E., Kirschfink M. Primary human hepatocytes are protected against complement by multiple regulators. Mol Immunol 2009, 46:2284-2289.
42. Krishna V.D., Rangappa M., Satchidanandam V. Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells. J Virol 2009, 83:4766-4777.
43. Furlan M., Lammle B. Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura-new insights into underlying biochemical mechanisms. Nephrol Dial Transplant 2000, 15:1112-1114.